Contact this trialFirst, we need to learn more about you.
Immunostimulant
Rintatolimod for Prostate Cancer
Recruiting1 awardPhase 2
Buffalo, New York
This trial is testing aspirin, rintatolimod, and interferon-alpha 2b to treat prostate cancer before surgery. The goal is to see if they can keep the cancer from coming back and slowing tumor growth.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.